{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:30:39Z","timestamp":1780493439212,"version":"3.54.1"},"reference-count":30,"publisher":"Wiley","license":[{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Biotechnol Progress"],"DOI":"10.1002\/btpr.3158","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T13:24:29Z","timestamp":1619184269000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Genetic rearrangement during site specific integration event facilitates cell line development of a bispecific molecule"],"prefix":"10.1002","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1162-7541","authenticated-orcid":false,"given":"Barbara","family":"Tevelev","sequence":"first","affiliation":[{"name":"Cell Line Development Biotherapeutics Pharmaceutical Sciences, Pfizer Inc.  Andover Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himakshi","family":"Patel","sequence":"additional","affiliation":[{"name":"Analytical Research and Development Biotherapeutics Pharmaceutical Sciences, Pfizer Inc.  Andover Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Shields","sequence":"additional","affiliation":[{"name":"Analytical Research and Development Biotherapeutics Pharmaceutical Sciences, Pfizer Inc.  Andover Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[{"name":"Cell Line Development Biotherapeutics Pharmaceutical Sciences, Pfizer Inc.  Andover Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Cooley","sequence":"additional","affiliation":[{"name":"Cell Line Development Biotherapeutics Pharmaceutical Sciences, Pfizer Inc.  Andover Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Zhang","sequence":"additional","affiliation":[{"name":"Cell Line Development Biotherapeutics Pharmaceutical Sciences, Pfizer Inc.  Andover Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Bitzas","sequence":"additional","affiliation":[{"name":"BioMedicine Design, Pfizer Inc.  Andover Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Duan","sequence":"additional","affiliation":[{"name":"BioMedicine Design, Pfizer Inc.  Andover Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lam","family":"Khetemenee","sequence":"additional","affiliation":[{"name":"BioMedicine Design, Pfizer Inc.  Andover Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Jackobek","sequence":"additional","affiliation":[{"name":"BioMedicine Design, Pfizer Inc.  Andover Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"D'Antona","sequence":"additional","affiliation":[{"name":"BioMedicine Design, Pfizer Inc.  Andover Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Sievers","sequence":"additional","affiliation":[{"name":"BioMedicine Design, Pfizer Inc.  Andover Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"King","sequence":"additional","affiliation":[{"name":"BioMedicine Design, Pfizer Inc.  Andover Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Tam","sequence":"additional","affiliation":[{"name":"BioMedicine Design, Pfizer Inc.  Andover Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[{"name":"BioMedicine Design, Pfizer Inc.  Andover Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Sousa","sequence":"additional","affiliation":[{"name":"BioMedicine Design, Pfizer Inc.  Andover Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Cohen","sequence":"additional","affiliation":[{"name":"BioMedicine Design, Pfizer Inc.  Andover Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lila","family":"Wroblewska","sequence":"additional","affiliation":[{"name":"BioMedicine Design, Pfizer Inc.  Andover Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Marshall","sequence":"additional","affiliation":[{"name":"Analytical Research and Development Biotherapeutics Pharmaceutical Sciences, Pfizer Inc.  Andover Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Jackson","sequence":"additional","affiliation":[{"name":"Analytical Research and Development Biotherapeutics Pharmaceutical Sciences, Pfizer Inc.  Andover Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3314-7602","authenticated-orcid":false,"given":"John J.","family":"Scarcelli","sequence":"additional","affiliation":[{"name":"Cell Line Development Biotherapeutics Pharmaceutical Sciences, Pfizer Inc.  Andover Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,5,12]]},"reference":[{"issue":"5","key":"e_1_2_7_2_1","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4161\/mabs.2.5.12720","article-title":"Cell culture processes for monoclonal antibody production","volume":"2","author":"Li F","year":"2010","journal-title":"MAbs"},{"issue":"3","key":"e_1_2_7_3_1","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00253-011-3758-5","article-title":"CHO cells in biotechnology for production of recombinant proteins: current state and further potential","volume":"93","author":"Kim JY","year":"2012","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"e_1_2_7_4_1","doi-asserted-by":"crossref","first-page":"e2724","DOI":"10.1002\/btpr.2724","article-title":"Transient CHO expression platform for robust antibody production and its enhanced N\u2010glycan sialylation on therapeutic glycoproteins","volume":"35","author":"Zhong X","year":"2019","journal-title":"Biotechnol Prog"},{"issue":"11","key":"e_1_2_7_5_1","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/nbt1026","article-title":"Production of recombinant protein therapeutics in cultivated mammalian cells","volume":"22","author":"Wurm FM","year":"2004","journal-title":"Nat Biotechnol"},{"issue":"5","key":"e_1_2_7_6_1","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.biotechadv.2011.08.022","article-title":"Mammalian cell protein expression for biopharmaceutical production","volume":"30","author":"Zhu J","year":"2012","journal-title":"Biotechnol Adv"},{"issue":"5","key":"e_1_2_7_7_1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4161\/mabs.1.5.9448","article-title":"Industrialization of mAb production technology: the bioprocessing industry at a crossroads","volume":"1","author":"Kelley B","year":"2009","journal-title":"MAbs"},{"issue":"5","key":"e_1_2_7_8_1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0958-1669(00)00127-0","article-title":"Site\u2010specific gene targeting for gene expression in eukaryotes","volume":"11","author":"Gorman C","year":"2000","journal-title":"Curr Opin Biotechnol"},{"issue":"14","key":"e_1_2_7_9_1","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.1007\/s00253-018-9021-6","article-title":"Rapid development of stable transgene CHO cell lines by CRISPR\/Cas9\u2010mediated site\u2010specific integration into C12orf35","volume":"102","author":"Zhao M","year":"2018","journal-title":"Appl Microbiol Biotechnol"},{"issue":"8","key":"e_1_2_7_10_1","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s10529-019-02702-5","article-title":"Feasible development of stable HEK293 clones by CRISPR\/Cas9\u2010mediated site\u2010specific integration for biopharmaceuticals production","volume":"41","author":"Yang H","year":"2019","journal-title":"Biotechnol Lett"},{"issue":"11","key":"e_1_2_7_11_1","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1002\/bit.26002","article-title":"Accelerated homology\u2010directed targeted integration of transgenes in Chinese hamster ovary cells via CRISPR\/Cas9 and fluorescent enrichment","volume":"113","author":"Lee JS","year":"2016","journal-title":"Biotechnol Bioeng"},{"issue":"8","key":"e_1_2_7_12_1","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/bit.26268","article-title":"A novel Bxb1 integrase RMCE system for high fidelity site\u2010specific integration of mAb expression cassette in CHO cells","volume":"114","author":"Inniss MC","year":"2017","journal-title":"Biotechnol Bioeng"},{"issue":"1","key":"e_1_2_7_13_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2012.11.016","article-title":"Recombinase\u2010mediated cassette exchange (RMCE) \u2010 a rapidly\u2010expanding toolbox for targeted genomic modifications","volume":"515","author":"Turan S","year":"2013","journal-title":"Gene"},{"issue":"11","key":"e_1_2_7_14_1","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1002\/bit.26388","article-title":"Preselection of recombinant gene integration sites enabling high transcription rates in CHO cells using alternate start codons and recombinase mediated cassette exchange","volume":"114","author":"Baumann M","year":"2017","journal-title":"Biotechnol Bioeng"},{"issue":"6","key":"e_1_2_7_15_1","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/btpr.2175","article-title":"Recombinase\u2010mediated cassette exchange (RMCE) for monoclonal antibody expression in the commercially relevant CHOK1SV cell line","volume":"31","author":"Zhang L","year":"2015","journal-title":"Biotechnol Prog"},{"issue":"7","key":"e_1_2_7_16_1","first-page":"1342","article-title":"Use of Flp\u2010mediated cassette exchange in the development of a CHO cell line stably producing erythropoietin","volume":"18","author":"Kim MS","year":"2008","journal-title":"J Microbiol Biotechnol"},{"issue":"9","key":"e_1_2_7_17_1","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1021\/acssynbio.8b00140","article-title":"Minimizing clonal variation during mammalian cell line engineering for improved systems biology data generation","volume":"7","author":"Grav LM","year":"2018","journal-title":"ACS Synth Biol"},{"key":"e_1_2_7_18_1","first-page":"e3137","article-title":"CHOK1SV GS\u2010KO SSI expression system: a combination of the Fer1L4 locus and glutamine synthetase selection","author":"Feary M","year":"2021","journal-title":"Biotechnol Prog"},{"key":"e_1_2_7_19_1","first-page":"38","article-title":"Fc engineering for developing therapeutic bispecific antibodies and novel scaffolds","volume":"8","author":"Liu H","year":"2017","journal-title":"Front Immunol"},{"issue":"3","key":"e_1_2_7_20_1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrd.2017.227","article-title":"Next generation antibody drugs: pursuit of the 'high\u2010hanging fruit'","volume":"17","author":"Carter PJ","year":"2018","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"e_1_2_7_21_1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1080\/19420862.2016.1268307","article-title":"The making of bispecific antibodies","volume":"9","author":"Brinkmann U","year":"2017","journal-title":"MAbs"},{"issue":"2","key":"e_1_2_7_22_1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molimm.2015.01.003","article-title":"Alternative molecular formats and therapeutic applications for bispecific antibodies","volume":"67","author":"Spiess C","year":"2015","journal-title":"Mol Immunol"},{"issue":"3","key":"e_1_2_7_23_1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jmb.2012.04.020","article-title":"Generating bispecific human IgG1 and IgG2 antibodies from any antibody pair","volume":"420","author":"Strop P","year":"2012","journal-title":"J Mol Biol"},{"issue":"7","key":"e_1_2_7_24_1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/protein\/9.7.617","article-title":"'Knobs\u2010into\u2010holes' engineering of antibody CH3 domains for heavy chain heterodimerization","volume":"9","author":"Ridgway JB","year":"1996","journal-title":"Protein Eng"},{"issue":"3","key":"e_1_2_7_25_1","first-page":"157","article-title":"Control of IgG LC:HC ratio in stably transfected CHO cells and study of the impact on expression, aggregation, glycosylation and conformational stability","volume":"165","author":"Ho SC","year":"2013","journal-title":"J Biotechnol"},{"key":"e_1_2_7_26_1","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1016\/j.csbj.2020.11.008","article-title":"Predicting favorable landing pads for targeted integrations in Chinese hamster ovary cell lines by learning stability characteristics from random transgene integrations","volume":"18","author":"Dhiman H","year":"2020","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"e_1_2_7_27_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/bit.26823","article-title":"Recurring genomic structural variation leads to clonal instability and loss of productivity","volume":"116","author":"Bandyopadhyay AA","year":"2019","journal-title":"Biotechnol Bioeng"},{"issue":"4","key":"e_1_2_7_28_1","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1073\/pnas.77.4.2197","article-title":"Immunoglobulin chain loss in hybridoma lines","volume":"77","author":"Kohler G","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"e_1_2_7_29_1","doi-asserted-by":"crossref","first-page":"7185","DOI":"10.1073\/pnas.81.22.7185","article-title":"Immunoglobulin heavy chain toxicity in plasma cells is neutralized by fusion to pre\u2010B cells","volume":"81","author":"Haas IG","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"e_1_2_7_30_1","doi-asserted-by":"crossref","first-page":"e110874","DOI":"10.1371\/journal.pone.0110874","article-title":"Clathrin heavy chain is important for viability, oviposition, embryogenesis and, possibly, systemic RNAi response in the predatory mite Metaseiulus occidentalis","volume":"9","author":"Wu K","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"e_1_2_7_31_1","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1093\/nar\/gky216","article-title":"A multi\u2010landing pad DNA integration platform for mammalian cell engineering","volume":"46","author":"Gaidukov L","year":"2018","journal-title":"Nucleic Acids Res"}],"container-title":["Biotechnology Progress"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/btpr.3158","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/btpr.3158","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/btpr.3158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T06:19:45Z","timestamp":1620800385000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/btpr.3158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,12]]},"references-count":30,"alternative-id":["10.1002\/btpr.3158"],"URL":"https:\/\/doi.org\/10.1002\/btpr.3158","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1002\/BTPR.3158\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/BTPR.3158\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/BTPR.3158\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/BTPR.3158\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/BTPR.3158\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/BTPR.3158\/v1\/review2","asserted-by":"object"}]},"ISSN":["8756-7938","1520-6033"],"issn-type":[{"value":"8756-7938","type":"print"},{"value":"1520-6033","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,12]]},"assertion":[{"value":"2021-03-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}